Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
|
Original-Research: Cantourage Group SE - from First Berlin Equity Research GmbH
Classification of First Berlin Equity Research GmbH to Cantourage Group SE
First Berlin Equity Research hat ein Research Update zu Cantourage Group SE (ISIN: DE000A3DSV01) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 11,00. Zusammenfassung: Die Cantourage Geschäftsführung arbeitet daran, die Finanzberichterstattung zu stärken und zu straffen, um die Transparenz hinsichtlich der operativen Leistung zu verbessern. Im Rahmen dieser Entwicklung hat der MedCan-Spezialist eine erste Jahresprognose veröffentlicht, die einen Umsatz von €85 Mio. bis €95 Mio. und ein AEBITDA von €10 Mio. bis €12 Mio. vorsieht. Diese neue Guidance schließt eine wichtige Lücke in der Vorhersehbarkeit, insbesondere nachdem die Kennzahlen des zweiten Quartals eine dramatische Verschiebung im Umsatzmix offenbarten, da Produkte aus Deutschland mit geringeren Margen bewusst zugunsten der Ertragsqualität reduziert wurden. Wir haben FBe nun auf den Mittelwert der Prognose neu kalibriert und dabei unsere Umsatzannahmen gesenkt, während wir die Ergebnisannahmen weitgehend unverändert gelassen haben. Die daraus resultierenden Modelländerungen haben nur geringfügige Auswirkungen auf die Bewertung, und unser Kursziel von €11 bleibt unverändert (88% Aufwärtspotenzial). Wir behalten unsere Kaufempfehlung für Cantourage bei. First Berlin Equity Research has published a research update on Cantourage Group SE (ISIN: DE000A3DSV01). Analyst Ellis Acklin reiterated his BUY rating and maintained his EUR 11.00 price target. Abstract: Cantourage brass are working to bolster and clean up financial reporting to improve transparency around operating performance. As part of this evolution, the MedCan specialist has published its initial 2026 guide calling for revenue of €85m to €95m and AEBITDA of €10m to €12m. The new guidance closes an important visibility gap, particularly after Q2 KPIs revealed a dramatic shift in the revenue mix as lower-margin German products were deliberately pruned in favour of earnings quality. We have now recalibrated FBe to the midpoint of guidance, lowering our topline assumptions while leaving earnings broadly intact. The resulting model changes have only a minor valuation impact, and our €11 TP remains unchanged (88% upside). We stay Buy-rated on Cantourage. Bezüglich der Pflichtangaben gem. §34b WpHG und des Haftungsausschlusses siehe die vollständige Analyse. You can download the research here: HIGH_GR-2026-09-03_EN Contact for questions: First Berlin Equity Research GmbH Herr Gaurav Tiwari Tel.: +49 (0)30 809 39 686 web: www.firstberlin.com E-Mail: g.tiwari@firstberlin.com
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
||||||||||||||||||||
2393302 03.09.2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 0,53 | 5,22 | 14,16 | 23,56 | 50,91 | 92,80 | 90,00 | |
| EBITDA1,2 | -0,56 | -0,83 | -2,51 | -0,25 | 3,48 | 5,70 | 11,00 | |
| EBITDA-Margin3 | -105,66 | -15,90 | -17,73 | -1,06 | 6,84 | 6,14 | 12,22 | |
| EBIT1,4 | -0,59 | -0,97 | -6,32 | -4,33 | -0,72 | 4,00 | 0,00 | |
| EBIT-Margin5 | -111,32 | -18,58 | -44,63 | -18,38 | -1,42 | 4,31 | 0,00 | |
| Net Profit (Loss)1 | -0,59 | -0,97 | -5,92 | 4,27 | -1,14 | 3,00 | 0,00 | |
| Net-Margin6 | -111,32 | -18,58 | -41,81 | 18,12 | -2,24 | 3,23 | 0,00 | |
| Cashflow1,7 | -0,56 | -0,83 | -2,11 | -0,20 | 3,07 | 6,00 | 0,00 | |
| Earnings per share8 | -0,05 | -0,08 | -0,47 | -0,34 | -0,09 | 0,24 | 0,31 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: PKF Wulf Gruppe
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Cantourage Group | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A3DSV0 | DE000A3DSV01 | SE | 69,82 Mio € | 11.11.2022 | Kaufen | 9F4MF9M4+93 |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 14,74 | 16,10 | 0,92 | -56,00 | 1,79 | 22,77 | 0,75 |
|
Dividend '2024 in € |
Dividend '2025 in € |
Dividend '2026e in € |
Div.-Yield '2026e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 24.06.2026 | 11.05.2026 | 13.08.2026 | 19.12.2025 | 15.05.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -3,63% | +11,93% | +65,19% | +53,01% | -13,58% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
